Therapeutic drug monitoring plays an important role in patients with noninfectious uveitis receiving adalimumab
ObjectiveTo evaluate the association between serum adalimumab (ADA) concentrations, antibodies against adalimumab (AAAs), tumor necrosis factor α (TNFα) levels, and clinical response in patients with noninfectious uveitis (NIU), as well as changes in T…